Showing 1471-1480 of 3103 results for "".
- External Suturing Technique May Enhance Back Contouring After Weight Losshttps://modernaesthetics.com/news/external-suturing-technique-may-enhance-back-contouring-after-weight-loss/2486607/A recent case series published in Plastic and Reconstructive Surgery–Global Open describes the use of external quilting sutures, or a “hemostatic net,” as an adjunct technique for lower back contouring in patients following massive weight loss. The report included 8 patients who u
- Interim IIT Data Explore Sculptra, Restylane for Menopause, Weight Loss–Related Aesthetic Changeshttps://modernaesthetics.com/news/interim-iit-data-explore-sculptra-restylane-for-menopause-weight-lossrelated-aesthetic-changes/2486595/Interim findings from 2 ongoing investigator-initiated trials supported by Galderma suggest potential roles for Sculptra and the Restylane portfolio in treating aesthetic changes associated with menopause and medication-driven weight loss. In one interim analysis led by Sabrina Fabi, MD, 2
- Merz Aesthetics Secures FDA Approval for RADIESSE in Décolleté Treatmenthttps://modernaesthetics.com/news/merz-aesthetics-secures-fda-approval-for-radiesse-in-decollete-treatment/2486550/Merz Aesthetics has received US Food and Drug Administration (FDA) approval for RADIESSE® (calcium hydroxylapatite [CaHA]) for the treatment of moderate to severe wrinkles in the décolleté in adults aged 22 years and older, according to a company announcement. The decision expands the
- GPX4 Modulator Shows Early Promise in First-in-Human Studyhttps://modernaesthetics.com/news/gpx4-modulator-shows-early-promise-in-first-in-human-study/2486474/A novel topical therapy targeting cellular senescence showed early biologic activity across multiple dermatologic conditions in a Phase 1 clinical trial, according to data presented by Frederick Beddingfield III, MD, PhD, FAAD, at the Dermatology Innovation Forum during the American Academy of De
- SkinPen Milestone Highlights Growth in Microneedling Demandhttps://modernaesthetics.com/news/skinpen-milestone-highlights-growth-in-microneedling-demand/2486459/Revance announced that it has distributed more than 1 million SkinPen treatment kits nationwide since January 2025, marking a milestone for the company’s microneedling portfolio. The achievement comes approximately 1 year after the launch of SkinPen Precision Elite, the latest iteration of the de
- Molecular Profiling Reveals Personalized Pathways in Skin Aginghttps://modernaesthetics.com/news/molecular-profiling-reveals-personalized-pathways-in-skin-aging/2486451/A translational biomarker study presented at the American Academy of Dermatology (AAD) 2026 Annual Meeting highlighted distinct molecular signatu
- AAD 2026: Lumenis Launches triLIFT 2.0 for Combined Muscle and Skin Rejuvenationhttps://modernaesthetics.com/news/lumenis-launches-trilift-20-for-combined-muscle-and-skin-rejuvenation/2486430/Lumenis Be Ltd. announced the commercial launch of triLIFT 2.0, a next-generation platform designed to deliver combined muscle stimulation and skin rejuvenation for facial and body applications. The system integrates Dynamic Muscle Stimulation technology (DMSt) with FibroBoost, aiming to address
- AAD 2026: CO2 Laser Resurfacing Linked to Transient Microbiome Shiftshttps://modernaesthetics.com/news/aad-2026-co2-laser-resurfacing-linked-to-transient-microbiome-shifts/2486399/New findings presented at the 2026 American Academy of Dermatology (AAD) Annual Meeting in Denver, Colorado, provide insight into dynamic microbiome changes following ablative CO2 laser resurfacing and their relationship to wound healing. In this monocentric, double-blind, rando
- Lynch Regenerative Medicine Expands PDGF Portfolio With GEM 21S® Distribution Agreementhttps://modernaesthetics.com/news/lynch-regenerative-medicine-expands-pdgf-portfolio-with-gem-21s-distribution-agreement/2486379/Lynch Regenerative Medicine, LLC (LRM) announced a definitive distribution agreement with Lynch Biologics, a Geistlich North America company, to commercialize GEM 21S®, an FDA-approved recombinant human platelet-derived growth factor (rhPDGF-BB) product, to licensed healthcare providers in the Un
- New Hydrobiome Serum Targets Skin Barrier and Microbiome Balancehttps://modernaesthetics.com/news/new-hydrobiome-serum-targets-skin-barrier-and-microbiome-balance/2486308/Epicutis has announced the launch of Hydrobiome Serum, a new addition to its clinical skincare portfolio developed in partnership with Signum Biosciences. The formulation is designed for patients with blemish-prone or congested skin and emphasizes microbiome balance and barrier support rather tha